176 related articles for article (PubMed ID: 17414222)
21. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris.
Pupita G; Maseri A; Kaski JC; Galassi AR; Gavrielides S; Davies G; Crea F
N Engl J Med; 1990 Aug; 323(8):514-20. PubMed ID: 2115977
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo.
Yada T; Shimokawa H; Hiramatsu O; Kajita T; Shigeto F; Tanaka E; Shinozaki Y; Mori H; Kiyooka T; Katsura M; Ohkuma S; Goto M; Ogasawara Y; Kajiya F
J Am Coll Cardiol; 2005 Feb; 45(4):599-607. PubMed ID: 15708710
[TBL] [Abstract][Full Text] [Related]
23. Involvement of Rho-kinase in vascular remodeling caused by long-term inhibition of nitric oxide synthesis in rats.
Ikegaki I; Hattori T; Yamaguchi T; Sasaki Y; Satoh SI; Asano T; Shimokawa H
Eur J Pharmacol; 2001 Sep; 427(1):69-75. PubMed ID: 11553365
[TBL] [Abstract][Full Text] [Related]
24. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
Jiang BH; Tawara S; Abe K; Takaki A; Fukumoto Y; Shimokawa H
J Cardiovasc Pharmacol; 2007 Feb; 49(2):85-9. PubMed ID: 17312448
[TBL] [Abstract][Full Text] [Related]
25. Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits.
Furuyama T; Komori K; Shimokawa H; Matsumoto Y; Uwatoku T; Hirano K; Maehara Y
J Vasc Surg; 2006 Jun; 43(6):1249-56. PubMed ID: 16765249
[TBL] [Abstract][Full Text] [Related]
26. Rho kinase inhibitor improves motor dysfunction and hypoalgesia in a rat model of lumbar spinal canal stenosis.
Ito T; Ohtori S; Hata K; Inoue G; Moriya H; Takahashi K; Yamashita T
Spine (Phila Pa 1976); 2007 Sep; 32(19):2070-5. PubMed ID: 17762807
[TBL] [Abstract][Full Text] [Related]
27. Effects of Rho-kinase inactivation on eosinophilia and hyper-reactivity in murine airways by allergen challenges.
Taki F; Kume H; Kobayashi T; Ohta H; Aratake H; Shimokata K
Clin Exp Allergy; 2007 Apr; 37(4):599-607. PubMed ID: 17430358
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice.
Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Kaibuchi K; Takeshita A
Circ Res; 2004 Jan; 94(1):46-52. PubMed ID: 14615290
[TBL] [Abstract][Full Text] [Related]
29. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms.
Matsumoto Y; Uwatoku T; Oi K; Abe K; Hattori T; Morishige K; Eto Y; Fukumoto Y; Nakamura K; Shibata Y; Matsuda T; Takeshita A; Shimokawa H
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):181-6. PubMed ID: 14592842
[TBL] [Abstract][Full Text] [Related]
30. [Involvement of small GTPase Rho and Rho-kinase in the pathogenesis of hypertension and hypertensive target organ damage].
Nakayama M; Amano M; Kawabata S; Kaibuchi K; Takefuji M
Nihon Rinsho; 2004 Mar; 62 Suppl 3():202-6. PubMed ID: 15171369
[No Abstract] [Full Text] [Related]
31. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
[TBL] [Abstract][Full Text] [Related]
32. [Continuous measurement of coronary sinus oxygen saturation in patients with effort angina and vasospastic angina].
Kikuchi F; Mikuniya A; Sawai M; Totsuka H; Tamura H; Chiba Y; Onodera K
J Cardiol; 1991; 21(4):857-68. PubMed ID: 1844441
[TBL] [Abstract][Full Text] [Related]
33. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis.
Sun X; Minohara M; Kikuchi H; Ishizu T; Tanaka M; Piao H; Osoegawa M; Ohyagi Y; Shimokawa H; Kira J
J Neuroimmunol; 2006 Nov; 180(1-2):126-34. PubMed ID: 16996142
[TBL] [Abstract][Full Text] [Related]
34. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
Yamashita K; Kotani Y; Nakajima Y; Shimazawa M; Yoshimura S; Nakashima S; Iwama T; Hara H
Brain Res; 2007 Jun; 1154():215-24. PubMed ID: 17482584
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of rho-kinase by hydroxyfasudil prevents vasopressin-induced myocardial ischemia in Donryu rats by attenuating coronary vasoconstriction.
Vincelette J; Pagila R; Kawai K; Ishii M; Horimizu Y; Vergona R; Sullivan ME; Morser J; Dole WP; Wang YX
Pharmacology; 2005 Nov; 75(3):145-51. PubMed ID: 16158013
[TBL] [Abstract][Full Text] [Related]
36. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.
Kanda T; Wakino S; Hayashi K; Homma K; Ozawa Y; Saruta T
Kidney Int; 2003 Dec; 64(6):2009-19. PubMed ID: 14633123
[TBL] [Abstract][Full Text] [Related]
37. Chronic stable angina pectoris.
Jawad E; Arora R
Dis Mon; 2008 Sep; 54(9):671-89. PubMed ID: 18725007
[No Abstract] [Full Text] [Related]
38. Coronary artery vasomotion and post-stenotic coronary artery blood flow after intracoronary lacidipine in patients with ischaemic heart disease: a pilot study.
Vassanelli C; Menegatti G; Marini A; Beltrame F; Molinari J; Cemin R
Drugs; 1999; 57 Suppl 1():19-26. PubMed ID: 10529079
[TBL] [Abstract][Full Text] [Related]
39. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm.
Kandabashi T; Shimokawa H; Miyata K; Kunihiro I; Eto Y; Morishige K; Matsumoto Y; Obara K; Nakayama K; Takahashi S; Takeshita A
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2209-14. PubMed ID: 14592852
[TBL] [Abstract][Full Text] [Related]
40. Differential role of rho-kinase in pathological and physiological cardiac hypertrophy in rats.
Balakumar P; Singh M
Pharmacology; 2006; 78(2):91-7. PubMed ID: 16974135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
